医学临床研究
  2025年4月5日 星期六           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2024, Vol. 41 Issue (10): 1475-1478    DOI: 10.3969/j.issn.1671-7171.2024.10.006
  论著 本期目录 | 过刊浏览 | 高级检索 |
乙酰半胱氨酸辅助无创呼吸机在老年COPD伴呼吸衰竭患者中的应用价值
李贤明
福建中医药大学附属人民医院呼吸科,福建 福州 350004
Application Value of Acetylcysteine-Assisted Noninvasive Ventilator in Elderly Patients with COPD and Respiratory Failure
LI Xianming
Department of Respiratory Medicine, Fujian University of Traditional Chinese Medicine Affiliated Hospital, Fuzhou Fujian 350004
全文: PDF (1217 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨乙酰半胱氨酸辅助无创呼吸机治疗老年慢性阻塞性肺疾病(COPD)伴呼吸衰竭患者的临床疗效。【方法】选取2020年12月至2023年4月在本院诊治的92例老年COPD合并呼吸衰竭患者,按照分层随机抽样法将患者分为对照组和观察组,每组46例。对照组接受无创呼吸机治疗,观察组在对照组基础上加用乙酰半胱氨酸治疗。比较两组呼吸动力学指标[呼吸频率(f)、潮气量(VT)、吸气时间(Ti)/呼吸周期总时间(Ttot)]、血气指标[氧合指数(OI)、血氧饱和度(SaO2)、动脉血二氧化碳分压(PaCO2)]、肺功能指标[呼吸流量峰值(PEF)、用力肺活量(FVC)、第1秒用力呼气容积(FEV1)]、血清指标[肾上腺髓质素前体中段肽(MRpro-ADM)、生长调节致癌基因α(GRO-α)、白介素-6(IL-6)、C反应蛋白(CRP)]水平、生活质量[圣·乔治呼吸问卷(SGRQ)评分]。【结果】治疗14 d后,观察组f低于对照组,VT、Ti/Ttot高于对照组(P<0.05);观察组OI、SaO2高于对照组,而PaCO2低于对照组(P<0.05);观察组PEF、FVC、FEV1高于对照组(P<0.05);观察组MRpro-ADM、GRO-α、IL-6、CRP水平低于对照组(P<0.05);观察组SGRQ评分低于对照组(P<0.05)。【结论】乙酰半胱氨酸辅助无创呼吸机治疗老年COPD合并呼吸衰竭患者,可显著改善患者氧合和通气功能,增强肺功能,降低炎症因子水平,提高患者生活质量,是一种有效的治疗方案。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
李贤明
关键词 肺疾病,慢性阻塞性呼吸功能不全乙酰半胱氨酸通气机,机械    
Abstract:【Objective】To investigate the clinical effect of acetylcysteine-assisted noninvasive ventilator in the treatment of elderly patients with chronic obstructive pulmonary disease (COPD) and respiratory failure. 【Methods】A total of 92 elderly patients with COPD and respiratory failure diagnosed and treated in our hospital from December 2020 to April 2023 were selected and divided into the control group and the observation group according to stratified random sampling method, with 46 cases in each group. The control group was treated with noninvasive ventilator, and the observation group was treated with acetyl cysteine combined with noninvasive ventilator. The two groups were compared in terms of respiratory dynamics parameters [respiratory rate (f), tidal volume (VT), inspiratory time (Ti)/ total respiratory cycle time (Ttot)], blood gas indicators [Oxygenation index (OI), oxygen saturation (SaO2), partial arterial pressure of carbon dioxide (PaCO2)], pulmonary function indicators [peak respiratory flow (PEF), forced vital capacity (FVC), forced expiratory volume in the first second (FEV1)], serum indicators [MRpro-ADM), Growth-regulated oncogene α (GRO-α), interleukin-6 (IL-6), C-reactive protein (CRP)] levels, quality of life [St. George&apos;s Respiratory Questionnaire (SGRQ) score]. 【Results】After 14 days of treatment, f in the observation group was lower than that in the control group, VT and Ti/Ttot were higher than that in the control group (P<0.05). OI and SaO2 in observation group were higher than those in the control group, while PaCO2 was lower than those in the control group (P<0.05). PEF, FVC and FEV1 in the observation group were higher than those in the control group (P<0.05). The levels of MRpro-ADM, GRO-α, IL-6 and CRP in the observation group were lower than those in the control group (P<0.05). The SGRQ score of the observation group was lower than that of the control group (P<0.05). 【Conclusion】Acetylcysteine-assisted non-invasive ventilator is an effective treatment for elderly patients with COPD complicated with respiratory failure, which can significantly improve the oxygenation and ventilation function, enhance lung function, reduce the level of inflammatory factors, and improve the quality of life of patients.
Key wordsPulmonary Disease, Chronic Obstructive    Respiratory Insufficiency    Acetylcysteine    Ventilators, Mechanical
收稿日期: 2023-12-27     
中图分类号:  R563  
引用本文:   
李贤明. 乙酰半胱氨酸辅助无创呼吸机在老年COPD伴呼吸衰竭患者中的应用价值[J]. 医学临床研究, 2024, 41(10): 1475-1478.
LI Xianming. Application Value of Acetylcysteine-Assisted Noninvasive Ventilator in Elderly Patients with COPD and Respiratory Failure. JOURNAL OF CLINICAL RESEARCH, 2024, 41(10): 1475-1478.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2024.10.006     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2024/V41/I10/1475
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn